There are few publications regarding the surgical treatment of obesity among super-super obese (SSO) patients undergoing sleeve gastrectomy (SG).The aim of this study is to examine weight outcomes (6, 12, and 24 months), presurgical comorbidities, and perioperative outcomes in SSO men and women patients undergoing SG.
Material and Methods:
This is a retrospective study with 109 SSO patients who underwent SG at the University of Illinois Hospital and Health Sciences System between January 2008 and June 2015.
Results:
Out of 674 patients who underwent SG, 109 (16.2%) were SSO. There were no significant differences in perioperative outcomes (operative time, length of hospitalization, and complication rates). Women had a greater percent excess weight loss (%EWL) (p = 0.039) and percent total weight loss (%TWL) (p = 0.026) than men at 6 months. Whereas at 12 and 24 months follow-up, there were no significant differences in %EWL and %TWL between SSO men and women.
Conclusions:
There were no significant differences in perioperative outcomes between SSO women and men. Percent EWL and %TWL during the 6-month follow-up was significantly greater in women versus men, but by 12 and 24 months, there were no significant differences in %EWL and %TWL between the two groups.
Get full access to this article
View all access options for this article.
References
1.
SantoMA, RiccioppoD, PajeckiD, ClevaR, KawamotoF, CecconelloI. Preoperative weight loss in super-obese patients: study of the rate of weight loss and its effects on surgical morbidity. Clinics (Sao Paulo), 2014; 69:828–834.
2.
OgdenCL, CarrollMD, FryarCD, FlegalKM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief, 2015:1–8.
3.
MalikVS, WillettWC, HuFB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol, 2013; 9:13–27.
4.
PonceJ, NguyenNT, HutterM, SudanR, MortonJM. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011–2014. Surg Obes Relat Dis, 2015; 11:1199–1200.
5.
StephensDJ, SaundersJK, BelsleyS, TrivediA, EwingDR, LannaceV, et al.Short-term outcomes for super-super obese (BMI > or = 60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass. Surg Obes Relat Dis, 2008; 4:408–415.
6.
GagnerM, GumbsAA, MiloneL, YungE, GoldenbergL, PompA. Laparoscopic sleeve gastrectomy for the super-super-obese (body mass index >60 kg/m(2)). Surg Today, 2008; 38:399–403.
7.
ThereauxJ, CzernichowS, CoriglianoN, PoitouC, OppertJM, BouillotJL. Five-year outcomes of gastric bypass for super-super-obesity (BMI>/ = 60 kg/m(2)): a case matched study. Surg Obes Relat Dis, 2015; 11:32–37.
8.
SerranoOK, TannebaumJE, CumellaL, ChoiJ, VemulapalliP, Scott MelvinW, et al.Weight loss outcomes and complications from bariatric surgery in the super super obese. Surg Endosc, 2015; 30:2505–2511.
9.
RoslinMS, CrippsC, PeristeriA. Bariatric and metabolic surgery: current trends and what's to follow. Curr Opin Gastroenterol, 2015; 31:513–518.
ReganJP, InabnetWB, GagnerM, PompA. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg, 2003; 13:861–864.
12.
BhatiaP, BindalV, SinghR, Gonzalez-HerediaR, KalhanS, KhetanM, et al.Robot-assisted sleeve gastrectomy in morbidly obese versus super obese patients. JSLS, 2014; 18:pii:e2014.00099.
13.
VillamereJ, GebhartA, VuS, NguyenNT. Body mass index is predictive of higher in-hospital mortality in patients undergoing laparoscopic gastric bypass but not laparoscopic sleeve gastrectomy or gastric banding. Am Surg, 2014; 80:1039–1043.
14.
WolfAM, BeisiegelU. The effect of loss of excess weight on the metabolic risk factors after bariatric surgery in morbidly and super-obese patients. Obes Surg, 2007; 17:910–919.
15.
KarmaliS, Johnson StoklossaC, SharmaA, StadnykJ, ChristiansenS, CottreauD, et al.Bariatric surgery: a primer. Can Fam Physician, 2010; 56:873–879.
16.
MageeCJ, BarryJ, ArumugasamyM, JavedS, MacadamR, KerriganDD. Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement—short-term results. Obes Surg, 2011; 21:547–550.
17.
PerroneF, BianciardiE, BenavoliD, TognoniV, NioluC, SiracusanoA, et al.Gender influence on long-term weight loss and comorbidities after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: a prospective study with a 5-year follow-up. Obes Surg, 2016; 26:276–281.
18.
StrohC, WeinerR, WolffS, KnollC, MangerT, Obesity Surgery WorkingG, et al.Are there gender-specific aspects in obesity and metabolic surgery? Data analysis from the German Bariatric Surgery Registry. Viszeralmedizin, 2014; 30:125–132.
19.
KushnirL, DunnicanWJ, BenedettoB, WangW, DolceC, LopezS, et al.Is BMI greater than 60 kg/m a predictor of higher morbidity after laparoscopic Roux-en-Y gastric bypass?. Surg Endosc, 2010; 24:94–97.
20.
BuchwaldH, EstokR, FahrbachK, BanelD, SledgeI. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery, 2007; 142:621–632; discussion 32–35.
21.
Sanchez-SantosR, VilarrasaN, PujolJ, MorenoP, Manuel FrancosJ, RafecasA, et al.Is Roux-en-Y gastric bypass adequate in the super-obese?. Obes Surg, 2006; 16:478–483.
22.
KralJG. Morbid obesity and related health risks. Ann Intern Med, 1985; 103(6 (Pt 2)):1043–1047.
23.
CathelineJM, FysekidisM, DboukR, BoschettoA, BihanH, ReachG, et al.Weight loss after sleeve gastrectomy in super superobesity. J Obes, 2012; 2012:959260.
24.
FarkasDT, VemulapalliP, HaiderA, LopesJM, GibbsKE, TeixeiraJA. Laparoscopic Roux-en-Y gastric bypass is safe and effective in patients with a BMI > or = 60. Obes Surg, 2005; 15:486–493.
25.
AbelesD, KimJJ, TarnoffME, ShahS, ShikoraSA. Primary laparoscopic gastric bypass can be performed safely in patients with BMI >or = 60. J Am Coll Surg, 2009; 208:236–240.
26.
MoonRC, NelsonL, TeixeiraAF, JawadMA. Outcomes of Roux-en-Y gastric bypass in the super obese: comparison of body mass index 50–60 kg/m(2) and>/ = 60 kg/m(2) with the morbidly obese. Surg Obes Relat Dis, 2016; 12:292–296.
27.
SchwartzA, EtchechouryL, ColletD. Outcome after laparoscopic gastric bypass for super-super obese patients. J Visc Surg, 2013; 150:145–149.
28.
HutterMM, SchirmerBD, JonesDB, KoCY, CohenME, MerkowRP, et al.First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg, 2011; 254:410–420; discussion 420–422.
29.
Ou YangO, LoiK, LiewV, TalbotM, JorgensenJ. Staged laparoscopic sleeve gastrectomy followed by Roux-en-Y gastric bypass for morbidly obese patients: a risk reduction strategy. Obes Surg, 2008; 18:1575–1580.
30.
NguyenNT, LongoriaM, GelfandDV, SabioA, WilsonSE. Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes Surg, 2005; 15:1077–1081.
31.
AlexandrouA, FelekourasE, GiannopoulosA, TsigrisC, DiamantisT. What is the actual fate of super-morbid-obese patients who undergo laparoscopic sleeve gastrectomy as the first step of a two-stage weight-reduction operative strategy?. Obes Surg, 2012; 22:1623–1628.
ToroJP, LinE, PatelAD. Review of robotics in foregut and bariatric surgery. Surg Endosc, 2015; 29:1–8.
34.
BuchsNC, MorelP, AzaguryDE, JungM, ChassotG, HuberO, et al.Laparoscopic versus robotic Roux-en-Y gastric bypass: lessons and long-term follow-up learned from a large prospective monocentric study. Obes Surg, 2014; 24:2031–2039.
35.
EconomopoulosKP, TheocharidisV, McKenzieTJ, SergentanisTN, PsaltopoulouT. Robotic vs. laparoscopic Roux-en-Y gastric bypass: a systematic review and meta-analysis. Obes Surg, 2015; 25:2180–2189.
36.
Kennedy-DalbyA, AdamS, AmmoriBJ, SyedAA. Weight loss and metabolic outcomes of bariatric surgery in men versus women - A matched comparative observational cohort study. Eur J Intern Med, 2014; 25:922–925.
37.
FarinholtGN, CarrAD, ChangEJ, AliMR. A call to arms: obese men with more severe comorbid disease and underutilization of bariatric operations. Surg Endosc, 2013; 27:4556–4563.
38.
PadwalRS, KlarenbachSW, WangX, SharmaAM, KarmaliS, BirchDW, et al.A simple prediction rule for all-cause mortality in a cohort eligible for bariatric surgery. JAMA Surg, 2013; 148:1109–1115.
39.
SucandyI, AntanaviciusG. Comparative analysis of gender differences in outcomes after biliopancreatic diversion with duodenal switch: revisiting male gender as a predictor for adverse outcomes in bariatric surgery. Am Surg, 2013; 79:543–544.
40.
TiwariMM, GoedeMR, ReynosoJF, TsangAW, OleynikovD, McBrideCL. Differences in outcomes of laparoscopic gastric bypass. Surg Obes Relat Dis, 2011; 7:277–282.
